Merck & Co., Inc.
MRK · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $5,787 | $4,429 | $5,085 | $3,744 |
| Dep. & Amort. | $1,154 | $1,119 | $1,099 | $1,197 |
| Deferred Tax | -$212 | -$448 | -$186 | -$616 |
| Stock-Based Comp. | $204 | $216 | $195 | $187 |
| Change in WC | $5,971 | -$2,259 | -$3,712 | -$1,855 |
| Other Non-Cash | -$5,082 | $236 | $19 | $793 |
| Operating Cash Flow | $7,822 | $3,293 | $2,500 | $3,450 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$987 | -$764 | -$1,328 | -$937 |
| Net Acquisitions | $0 | $0 | $0 | -$2 |
| Inv. Purchases | -$473 | -$612 | -$685 | -$455 |
| Inv. Sales/Matur. | $575 | $601 | $456 | $7 |
| Other Inv. Act. | $602 | $5 | $70 | -$57 |
| Investing Cash Flow | -$283 | -$770 | -$1,487 | -$1,444 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $48 | -$2,500 | -$539 |
| Stock Issued | $0 | $0 | $19 | $0 |
| Stock Repurch. | $2,490 | -$1,345 | -$1,164 | -$489 |
| Dividends Paid | -$2,031 | -$2,077 | -$2,050 | -$1,951 |
| Other Fin. Act. | $2,179 | -$182 | -$60 | -$30 |
| Financing Cash Flow | $2,638 | -$3,556 | -$5,755 | -$3,009 |
| Forex Effect | $10 | $374 | $156 | -$367 |
| Net Chg. in Cash | $10,187 | -$659 | -$4,586 | -$1,370 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,073 | $8,732 | $13,318 | $14,688 |
| End Cash | $18,260 | $8,073 | $8,732 | $13,318 |
| Free Cash Flow | $6,835 | $2,529 | $1,172 | $2,513 |